STOCK TITAN
  1. Home
  2. Sec-filings
  3. VMD
  4. [Form 4] VIEMED HEALTHCARE, INC. Insider Trading Activity

Viemed Healthcare (NASDAQ: VMD) grants new RSUs and phantom units to director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

VIEMED HEALTHCARE, INC. (VMD) director Sabrina Heltz reported several equity-compensation transactions. On August 19, 2026, 15,029 Restricted Stock Units and 3,757 Phantom Share Units vested and were converted into common shares, with the phantom-share-related common shares simultaneously returned to the company for cash at $8.94 per share. On August 17, 2026, she received new awards of 12,174 RSUs and 3,043 Phantom Share Units, each representing one common share or its cash value and scheduled to vest on the first anniversary of the grant date, with the RSUs expiring on August 17, 2027.

Positive

  • None.

Negative

  • None.
Insider Heltz Sabrina
Role Director
Type Security Shares Price Value
Exercise Restricted Stock Units F1, F4 15,029 $0.00 $0.00
Exercise Phantom Share Units F2, F5 3,757 $0.00 $0.00
Exercise Common Shares F1 15,029 -- --
Exercise Common Shares F2 3,757 -- --
Disposition Common Shares F3 3,757 $8.94 $34K
Grant/Award Restricted Stock Units F1, F6 12,174 $0.00 $0.00
Grant/Award Phantom Share Units F7, F8 3,043 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 12,174 shares (Direct); Phantom Share Units — 3,043 shares (Direct); Common Shares — 82,520 shares (Direct)
Footnotes (8)
  1. F1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
  2. F2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
  3. F3. Per share value is based on the market closing price of the common shares for August 19, 2026.
  4. F4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
  5. F5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
  6. F6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
  7. F7. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
  8. F8. Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.
RSUs vested 15,029 shares Restricted Stock Units converted into common shares on August 19, 2026
Phantom Share Units vested 3,757 units Phantom Share Units settled for cash on August 19, 2026
New RSU grant 12,174 units RSUs granted on August 17, 2026, vesting after one year
New Phantom Share Unit grant 3,043 units Phantom Share Units granted on August 17, 2026, vesting after one year
Disposition price $8.94 per share Cash-settlement value for 3,757 common shares on August 19, 2026
RSU expiration August 17, 2027 Expiration date of RSUs granted August 17, 2026
Restricted Stock Units financial
"Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Phantom Share Units financial
"Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan"
cash-settled phantom shares financial
"Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan"
economic equivalent financial
"Each phantom share is the economic equivalent of one Company common share"

FAQ

What equity awards did VMD director Sabrina Heltz receive on August 17, 2026?
On August 17, 2026, Sabrina Heltz received 12,174 Restricted Stock Units and 3,043 Phantom Share Units. Each unit corresponds to one VMD common share or its cash value and is scheduled to vest on the first anniversary of the grant date.

What happened to Sabrina Heltz’s VMD RSUs on August 19, 2026?
On August 19, 2026, 15,029 Restricted Stock Units vested for Sabrina Heltz and were converted into an equal number of VMD common shares. These RSUs had been granted on August 19, 2025 and vested on their one-year anniversary.

How were Sabrina Heltz’s VMD Phantom Share Units settled on August 19, 2026?
On August 19, 2026, 3,757 Phantom Share Units vested and were settled for cash. The settlement is reported as acquiring 3,757 VMD common shares and a simultaneous disposition of those shares back to the company in exchange for cash.

At what price were some of Sabrina Heltz’s VMD common shares valued in the August 19, 2026 transaction?
In the August 19, 2026 cash-settlement transaction, 3,757 VMD common shares were valued at $8.94 per share. This per-share value was based on the market closing price of VMD common shares on August 19, 2026, according to the filing footnote.

When do Sabrina Heltz’s newly granted VMD RSUs and Phantom Share Units vest and expire?
The 12,174 RSUs and 3,043 Phantom Share Units granted on August 17, 2026 vest on the first anniversary of the grant date. The RSUs have an expiration date of August 17, 2027, while the phantom units pay cash value based on the share price at vesting.

Did the August 2026 Form 4 for VMD indicate trading under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5-1 checkbox was not marked as being made under such a plan. The transactions are therefore not identified in the filing as executed pursuant to a pre-arranged Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Heltz Sabrina
(Last)(First)(Middle)
625 E. KALISTE SALOOM RD.
(Street)
LAFAYETTE LOUISIANA 70508
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares08/19/2026M15,029A(1)82,520D
Common Shares08/19/2026M3,757A(2)86,277D
Common Shares08/19/2026D3,757D$8.94(3)82,520D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)08/19/2026M15,029 (4) (4)Common Shares15,029$00D
Phantom Share Units(2)08/19/2026M3,757 (5) (5)Common Shares3,757$00D
Restricted Stock Units(1)08/17/2026A12,174 (6)08/17/2027Common Shares12,174$012,174D
Phantom Share Units(7)08/17/2026A3,043 (8)08/17/2027Common Shares3,043$03,043D
Explanation of Responses:
1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
2. Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
3. Per share value is based on the market closing price of the common shares for August 19, 2026.
4. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.
5. On August 19, 2025, the reporting person was granted Phantom Share Units which vest on August 19, 2026.
6. Restricted Stock Units (RSUs) granted to reporting person on August 17, 2026, which vest on the first anniversary of the grant date.
7. Each phantom share represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
8. Represents an award granted on August 17, 2026 under the Issuer's Phantom Share Plan which vests on the first anniversary of the grant date.
Remarks:
/s/ Jesse Bergeron, Attorney-in-Fact08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR